Business

Zealand Pharma Stock Plummets

Updated 2026-06-19 05:40 UTC 1 source Negative

Zealand Pharma's stock suffered its two worst days on record. Investors are now focusing on amylin-based medicines as a potential growth driver.

Coverage timeline — 1 article

CNBC

Zealand Pharma stock suffered its two worst days on record. Here's what's next for the weight loss drugmaker

While the market's enthusiasm for one of Zealand's experimental drugs has cooled, investors are shifting focus to amylin-based medicines as a growth driver

2026-06-19 05:00 UTC